These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15987496)

  • 1. Soluble RAGE: a hot new biomarker for the hot joint?
    Moser B; Hudson BI; Schmidt AM
    Arthritis Res Ther; 2005; 7(4):142-4. PubMed ID: 15987496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis.
    Chen YS; Yan W; Geczy CL; Brown MA; Thomas R
    Arthritis Res Ther; 2009; 11(2):R39. PubMed ID: 19284577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.
    Kim JK; Park S; Lee MJ; Song YR; Han SH; Kim SG; Kang SW; Choi KH; Kim HJ; Yoo TH
    Atherosclerosis; 2012 Jan; 220(1):208-14. PubMed ID: 21906738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity.
    Yilmaz Y; Yonal O; Eren F; Atug O; Hamzaoglu HO
    J Crohns Colitis; 2011 Oct; 5(5):402-6. PubMed ID: 21939913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels.
    Myles A; Viswanath V; Singh YP; Aggarwal A
    J Rheumatol; 2011 Sep; 38(9):1994-9. PubMed ID: 21724696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritis.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Rheumatology (Oxford); 2007 Aug; 46(8):1367-71. PubMed ID: 17569744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease.
    Mahajan N; Malik N; Bahl A; Dhawan V
    Atherosclerosis; 2009 Dec; 207(2):597-602. PubMed ID: 19576587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total soluble and endogenous secretory receptor for advanced glycation endproducts (RAGE) in IBD.
    Meijer B; Hoskin T; Ashcroft A; Burgess L; Keenan JI; Falvey J; Gearry RB; Day AS
    J Crohns Colitis; 2014 Jun; 8(6):513-20. PubMed ID: 24291021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
    Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
    Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts.
    Ramasamy R; Yan SF; Schmidt AM
    J Leukoc Biol; 2009 Sep; 86(3):505-12. PubMed ID: 19477910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The receptor for advanced glycation end products (RAGE) system in women with intraamniotic infection and inflammation.
    Buhimschi IA; Zhao G; Pettker CM; Bahtiyar MO; Magloire LK; Thung S; Fairchild T; Buhimschi CS
    Am J Obstet Gynecol; 2007 Feb; 196(2):181.e1-13. PubMed ID: 17306673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
    Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
    Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
    Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) may reflect tissue RAGE expression in diabetes.
    Yamagishi S; Imaizumi T
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):e32; author reply e33-4. PubMed ID: 17522392
    [No Abstract]   [Full Text] [Related]  

  • 17. Receptor for advanced glycation end-product (RAGE) gene polymorphism 2245G/A is associated with pro-inflammatory, oxidative-glycation markers and sRAGE in diabetic retinopathy.
    Ng ZX; Kuppusamy UR; Iqbal T; Chua KH
    Gene; 2013 Jun; 521(2):227-33. PubMed ID: 23545311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
    Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
    Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases.
    Maillard-Lefebvre H; Boulanger E; Daroux M; Gaxatte C; Hudson BI; Lambert M
    Rheumatology (Oxford); 2009 Oct; 48(10):1190-6. PubMed ID: 19589888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
    Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
    Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.